VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial

HealthEquity Executive Compensation (FY26)

HQY · Draper, UT · Executive and director compensation, fiscal 2022 to 2026
Chief executive, fiscal 2026
◇
Scott Cutler
Median of the other named officers
$4,180,404
5 officers, excluding the chief executive
Latest say-on-pay support
=
June 25, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing

The HealthEquity brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $900.
15 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
HealthEquity brief$500Get the executive brief
Velarion Intel, one year, every company
331 figures on this page: 320 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
What changed from fiscal 2025 to fiscal 2026
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Scott Cutler: $8,277,080 → $13,582,105 (64.1% higher)
CEO pay ratio: 151:1 → 174:1 (15.2% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is HealthEquity's chief executive and what were they paid?
Scott Cutler was paid $13,582,105 in total compensation as President and Chief Executive Officer for fiscal 2026. Cutler's total was 64.1% higher than the $8,277,080 reported for fiscal 2025.
What was HealthEquity's say-on-pay result?
For fiscal 2026, shareholders backed the say-on-pay proposal with 97.6% of votes cast for or against in favor at the meeting held June 25, 2026.
Which companies are in HealthEquity's peer group?
Companies named in the disclosed peer group include ACI Worldwide, Inc., Alight, Inc., BlackBaud, Inc., CorVel Corporation and Dayforce, Inc., among others.
What is HealthEquity's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2026 is 174:1, against median employee compensation of $77,904.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jon Kessler
President & Chief Executive Officer
◇—◇—◇—◇◇
Edward Bloomberg
Executive Vice President and Chief Operating Officer
◇—◇—◇—◇◇
Tyson Murdock
Executive Vice President and Chief Financial Officer
◇—◇—◇—◇◇
Stephen Neeleman
Founder and Vice Chairman
◇—◇—◇—◇◇
Larry Trittschuh
Executive Vice President and Chief Security Officer
◇—◇—◇—◇◇
Darcy Mott
Former Executive VicePresident and Chief Financial Officer
Departed during or after this year
◇—————◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jon Kessler
President & Chief Executive Officer
◇—◇—◇—◇◇
Elimelech Rosner
Executive Vice President and Chief Technology Officer
◇◇◇—◇—◇◇
Edward Bloomberg
Former Executive Vice President and Chief Operating Officer
Departed during or after this year
◇—◇—◇—◇◇
Tyson Murdock
Executive Vice President and Chief Financial Officer
◇—◇—◇—◇◇
Larry Trittschuh
Executive Vice President and Chief Security Officer
◇—◇—◇—◇◇
Stephen Neeleman
Founder and Vice Chairman
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Jon Kessler
Former President and Chief Executive Officer
Departed during or after this year
◇—◇—◇—◇◇
James Lucania
Executive Vice President and Chief Financial Officer
◇—◇—◇—◇◇
Elimelech Rosner
Executive Vice President and Chief Technology Officer
◇—◇—◇—◇◇
Stephen Neeleman
Founder and Vice Chairman
◇—◇—◇—◇◇
Delano Ladd
Executive Vice President and General Counsel
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Scott Cutler
President and Chief Executive Officer
◇◇◇—◇—◇◇
Michael Fiore
Executive Vice President and Chief Commercial Officer
◇—◇—◇—◇◇
Selim Aissi
Former Executive Vice President and Chief Security Officer
Departed during or after this year
◇—◇—◇—◇◇
Fiscal 2026
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Scott Cutler
President and Chief Executive Officer
◇—◇—◇—◇◇
James Lucania
Executive Vice President and Chief Financial Officer
◇—◇—◇—◇◇
Elimelech Rosner
Former Executive Vice President and Chief Technology Officer
Departed during or after this year
◇—◇—◇—◇◇
Michael Fiore
Executive Vice President and Chief Commercial Officer
◇—◇—◇—◇◇
Delano Ladd
Executive Vice President and General Counsel
◇—◇—◇—◇◇
Stephen Neeleman
Founder and Vice Chairman
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2026
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Delano LaddPSU◇◇◇—◇—◇
Delano LaddRSU◇——◇——◇
Elimelech RosnerPSU◇◇◇—◇—◇
Elimelech RosnerRSU◇——◇——◇
James LucaniaPSU◇◇◇—◇—◇
James LucaniaRSU◇——◇——◇
Michael FiorePSU◇◇◇—◇—◇
Michael FioreRSU◇——◇——◇
Scott CutlerPSU◇◇◇—◇—◇
Scott CutlerRSU◇——◇——◇
Stephen NeelemanRSU◇——◇——◇
Stephen NeelemanPSU◇◇◇—◇—◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2026 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Scott CutlerPSU◇◇——
RSU◇◇——
RSU◇◇——
Elimelech RosnerPSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
James LucaniaPSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Michael FioreRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
Stephen NeelemanPSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Delano LaddPSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Elimelech Rosner
Former Executive Vice President and Chief Technology Officer · Employment agreement
Severance multiple◇
Severance base◇
Change-in-control trigger◇
Benefits continuation◇
Non-solicit period◇

Director compensation

What each non-employee director was paid.
Fiscal 2026
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Robert Selander
Board chair
◇◇————◇
Adrian Dillon
◇◇————◇
Evelyn Dilsaver
◇◇———◇◇
Stuart Parker
◇◇———◇◇
Gayle Wellborn
◇◇————◇
Rajesh Natarajan
◇◇————◇
Debra McCowan
◇◇————◇
Paul Black
◇—————◇
Scott Cutler, Stephen Neeleman and William Gassen served on the board in fiscal 2026 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2026
  • ACI Worldwide, Inc. ACIW
  • Alight, Inc. ALIT
  • BlackBaud, Inc. BLKB
  • CorVel Corporation CRVL
  • Dayforce, Inc. DAY
  • Envestnet, Inc. ENV
  • Evolent Health, Inc. EVH
  • Guidewire Software Inc. GWRE
  • Omnicell, Inc. OMCL
  • Paycom Software, Inc. PAYC
  • Paycor HCM, Inc. PYCR
  • Paylocity Holding Corporation PCTY
  • Pegasystems, Inc. PEGA
  • Progyny, Inc. PGNY
  • Tyler Technologies, Inc. TYL
  • Verint Systems Inc. VRNT
  • WEX Inc. WEX

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2026June 25, 2026=◇◇◇
2025June 26, 2025=◇◇◇
2024June 26, 2025=◇◇◇
2023June 27, 2024=◇◇◇
2022June 22, 2023=◇◇◇
2021June 23, 2022=◇◇◇
2020June 24, 2021=◇◇◇
2019June 25, 2020=◇◇◇
2018June 27, 2019=◇◇◇
2017June 21, 2018=◇◇◇
2016June 22, 2017=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Scott Cutler (President and Chief Executive Officer), FY2026 total compensation $13,582,105 (base salary $775,000) [exec_comp, SEC accession 0001428336-26-000022, filed 2026-05-13]

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when HealthEquity files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact HealthEquity disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where HealthEquity sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether HealthEquity's disclosed peer group is defensible, who names HealthEquity back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
331 figures on this page: 320 cited to the filing that reported them, 11 calculated from figures it prints.
320 cited to the filing
11 calculated from the filing

Documents cited

  1. 0001428336-26-000034
    Proposal 3. The approval, on a non-binding, advisory basis, of the fiscal 2026 compensation paid to the Company’s named executive officers.
  2. 0001428336-26-000022
    CEO Pay Ratio · Director Compensation · Fiscal 2026 Director Compensation Table · Fiscal 2026 Outstanding Equity Awards at Fiscal Year-End Table · and 2 more sections
  3. 0001428336-25-000024
    Proposal 3. The approval, on a non-binding, advisory basis, of the fiscal 2025 compensation paid to the Company’s named executive officers.
  4. 0001428336-25-000016
    Summary Compensation Table
  5. 0001428336-24-000048
  6. 0001428336-23-000026
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0001104659-23-059479
    Summary Compensation Table
  8. 0001428336-23-000014
    EX-10.11
  9. 0001428336-22-000020
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001104659-22-059734
    Summary Compensation Table
  11. 0001428336-21-000029
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0001428336-20-000021
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0001428336-19-000015
    Item 5.07 Submission of Matters to a Vote of Security Holders
  14. 0001428336-18-000019
    Item 5.07 Submission of Matters to a Vote of Security Holders
  15. 0001428336-17-000018
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “HealthEquity executive compensation, FY2022–FY2026.” https://intel.velarion.ai/comp/HQY (accessed 2026).
Short form: data: Velarion

The HealthEquity brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $900.
15 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about HealthEquity and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

Peers HealthEquity discloses

The companies named in HQY's own disclosed peer group.

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}